This study uncovers the previously unknown role of HLJ1 in suppressing liver cancer with peritumoral STAT3 inhibition, and thus HLJ1 reinforcement could be a promising strategy for both liver cancer treatment and prevention. The gene discussed is STAT3; the disease is liver cancer.